Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
KGHM launches $8.55 billion investment plan

KGHM launches $8.55 billion investment plan

Mining.comMining.com2026/07/03 13:58
By:Mining.com

Polish state-controlled copper and silver producer KGHM on Friday set a new strategy committing more than 32 billion zlotys ($8.55 billion) in investment through the end of the decade while setting new output and profit targets.

var rnd = window.rnd || Math.floor(Math.random() * 10e6); var pid472436 = window.pid472436 || rnd; var plc472436 = window.plc472436 || 0; var abkw = window.abkw || ''; var absrc = 'https://servedbyadbutler.com/adserve/;ID=181210;size=0x0;setID=472436;type=js;sw=' + screen.width + ';sh=' + screen.height + ';spr=' + window.devicePixelRatio + ';kw=' + abkw + ';pid=' + pid472436+ ';place=' + (plc472436++) + ';rnd=' + rnd + ';click=CLICK_MACRO_PLACEHOLDER'; document.write('
');

The plan, called “Strategy 2055+,” targets average annual adjusted core profit, measured as earnings before interest, taxes, depreciation and amortisation (EBITDA), of 12 billion zlotys, paid copper output of 730,000 tonnes and silver production of 1,290 tonnes between 2026 and 2030.

“After 2035, we want KGHM to be a modern, multi-raw material industrial group,” Chief Executive Remigiusz Paszkiewicz said, adding the company planned to build a new mine dubbed “KGHM 2.0” in Poland.

The plan reflects KGHM’s push to ore supplies closer to its Polish smelters and to cut logistics costs. The company expects about 80% of copper output to come from domestic assets, with the rest from mines abroad.

The strategy also places fresh emphasis on overseas operations.

KGHM said nearly 80% of planned investment would go to its core Polish business, with the rest allocated to assets in Chile, the U.S. and Canada. Overseas assets generated about 48% of the group’s EBITDA in 2025, helped by the Sierra Gorda mine in Chile, in which KGHM owns a 55% stake, and the Robinson mine in Nevada.

“We want the position of our foreign assets to grow, because this builds the company’s global credibility and resilience to structural changes,” Deputy Chief Executive for foreign assets Anna Sobieraj-Kozakiewicz said.

She said the company would seek new opportunities based on efficiency analysis.

($1 = 3.7415 zlotys)

(Reporting by Alicja Surdy, additional reporting by Rafal Nowak; Editing by Matt Scuffham)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales